Maddocks

As it fends off a suit by AstraZeneca seeking to block the sale of a cheaper version of Brilinta, generics maker Pharmacor claims a patent for the heart attack drug should not have been extended.

Logistics giant Qube has partially prevailed in setting aside amounts Martinus Rail claimed it was owed under a contract for work at an intermodal freight terminal in Moorebank, NSW.

The corporate watchdog is suing the second Big Four bank in two months, alleging NAB mishandled hundreds of hardship applications from vulnerable customers.

Rugby Australia is considering an insolvent trading cross-claim against the directors of the Melbourne Rebels, in a suit by the failed team which was cut from next year’s Super Rugby Pacific competition.

Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.

Holding Redlich has lost a veteran environment partner with extensive experience representing government clients and his team to Maddocks, marking the firm's second lateral loss this week.

Logistics giant Qube has won a $40 million cut to amounts owed to Martinus Rail in a dispute over construction of the Moorebank terminal project in Sydney's west.

Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug. 

White & Case has snagged a partner from Maddocks with more than 25 years of experience in corporate real estate to assist the firm on global transactions and restructurings. 

The French association representing wine producers from Champagne has discontinued its lawsuit against an Australian retailer after it agreed to only use seed extract from the Champagne region of France.